These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 9423888)
1. Capsular polysaccharide-fimbrial protein conjugate vaccine protects against Porphyromonas gingivalis infection in SCID mice reconstituted with human peripheral blood lymphocytes. Choi JI; Schifferle RE; Yoshimura F; Kim BW Infect Immun; 1998 Jan; 66(1):391-3. PubMed ID: 9423888 [TBL] [Abstract][Full Text] [Related]
2. Modification of experimental Porphyromonas gingivalis murine infection by immunization with a polysaccharide-protein conjugate. Schifferle RE; Chen PB; Davern LB; Aguirre A; Genco RJ; Levine MJ Oral Microbiol Immunol; 1993 Oct; 8(5):266-71. PubMed ID: 8265201 [TBL] [Abstract][Full Text] [Related]
3. A peptide domain on gingipain R which confers immunity against Porphyromonas gingivalis infection in mice. Genco CA; Odusanya BM; Potempa J; Mikolajczyk-Pawlinska J; Travis J Infect Immun; 1998 Sep; 66(9):4108-14. PubMed ID: 9712755 [TBL] [Abstract][Full Text] [Related]
4. Prior exposure of mice to Fusobacterium nucleatum modulates host response to Porphyromonas gingivalis. Choi J; Borrello MA; Smith E; Cutler CW; Sojar H; Zauderer M Oral Microbiol Immunol; 2001 Dec; 16(6):338-44. PubMed ID: 11737656 [TBL] [Abstract][Full Text] [Related]
5. Mucosal immunization with a flagellin-adjuvanted Hgp44 vaccine enhances protective immune responses in a murine Porphyromonas gingivalis infection model. Puth S; Hong SH; Park MJ; Lee HH; Lee YS; Jeong K; Kang IC; Koh JT; Moon B; Park SC; Rhee JH; Lee SE Hum Vaccin Immunother; 2017 Dec; 13(12):2794-2803. PubMed ID: 28604268 [TBL] [Abstract][Full Text] [Related]
6. Immunization with Porphyromonas gingivalis capsular polysaccharide prevents P. gingivalis-elicited oral bone loss in a murine model. Gonzalez D; Tzianabos AO; Genco CA; Gibson FC Infect Immun; 2003 Apr; 71(4):2283-7. PubMed ID: 12654858 [TBL] [Abstract][Full Text] [Related]
7. Vaccination with recombinant RgpA peptide protects against Porphyromonas gingivalis-induced bone loss. Wilensky A; Potempa J; Houri-Haddad Y; Shapira L J Periodontal Res; 2017 Apr; 52(2):285-291. PubMed ID: 27282938 [TBL] [Abstract][Full Text] [Related]
9. Immunization by Arg-gingipain A DNA vaccine protects mice against an invasive Porphyromonas gingivalis infection through regulation of interferon-gamma production. Yonezawa H; Kato T; Kuramitsu HK; Okuda K; Ishihara K Oral Microbiol Immunol; 2005 Oct; 20(5):259-66. PubMed ID: 16101960 [TBL] [Abstract][Full Text] [Related]
10. Intranasal immunization with Porphyromonas gingivalis and atherosclerosis. Koizumi Y; Kurita-Ochiai T; Oguchi S; Yamamoto M Immunopharmacol Immunotoxicol; 2009; 31(3):352-7. PubMed ID: 19555215 [TBL] [Abstract][Full Text] [Related]
11. Immunochemical characterisation and epitope mapping of a novel fimbrial protein (Pg-II fimbria) of Porphyromonas gingivalis. Ogawa T; Yasuda K; Yamada K; Mori H; Ochiai K; Hasegawa M FEMS Immunol Med Microbiol; 1995 Jun; 11(3):247-55. PubMed ID: 7581276 [TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of a cholera toxin B subunit Porphyromonas gingivalis fimbrial antigen fusion protein expressed in E. coli. Kim TG; Huy NX; Kim MY; Jeong DK; Jang YS; Yang MS; Langridge WH; Lee JY Mol Biotechnol; 2009 Feb; 41(2):157-64. PubMed ID: 18807220 [TBL] [Abstract][Full Text] [Related]
13. Arg-gingipain a DNA vaccine induces protective immunity against infection by Porphyromonas gingivalis in a murine model. Yonezawa H; Ishihara K; Okuda K Infect Immun; 2001 May; 69(5):2858-64. PubMed ID: 11292699 [TBL] [Abstract][Full Text] [Related]
14. Gingipains as candidate antigens for Porphyromonas gingivalis vaccine. Nakagawa T; Saito A; Hosaka Y; Ishihara K Keio J Med; 2003 Sep; 52(3):158-62. PubMed ID: 14529148 [TBL] [Abstract][Full Text] [Related]
15. The potential protective immune responses to synthetic peptides containing conserved epitopes of Porphyromonas gingivalis fimbrial protein. Ogawa T J Med Microbiol; 1994 Nov; 41(5):349-58. PubMed ID: 7966208 [TBL] [Abstract][Full Text] [Related]
16. Host responses to recombinant hemagglutinin B of Porphyromonas gingivalis in an experimental rat model. Katz J; Black KP; Michalek SM Infect Immun; 1999 Sep; 67(9):4352-9. PubMed ID: 10456874 [TBL] [Abstract][Full Text] [Related]
17. Prevention of Porphyromonas gingivalis-induced oral bone loss following immunization with gingipain R1. Gibson FC; Genco CA Infect Immun; 2001 Dec; 69(12):7959-63. PubMed ID: 11705986 [TBL] [Abstract][Full Text] [Related]
18. Porphyromonas gingivalis B cell Antigen Epitope Vaccine, pIRES-ragB'-mGITRL, Promoted RagB-Specific Antibody Production and Tfh Cells Expansion. Kong F; Zheng D; She P; Ni P; Zhu H; Xu H; Su Z Scand J Immunol; 2015 Jun; 81(6):476-82. PubMed ID: 25689343 [TBL] [Abstract][Full Text] [Related]
20. Effectiveness of the B subunit of cholera toxin in potentiating immune responses to the recombinant hemagglutinin/adhesin domain of the gingipain Kgp from Porphyromonas gingivalis. Zhang P; Yang QB; Balkovetz DF; Lewis JP; Clements JD; Michalek SM; Katz J Vaccine; 2005 Sep; 23(39):4734-44. PubMed ID: 15955601 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]